David Dorn, MD
Aurora Diagnostics Welcomes David Dorn, MD, Anatomic Pathologist, to our Cunningham Pathology staff. Cunningham Pathology is pleased to announce the addition of David Dorn, MD to our full-service...
View ArticleSophia Ma, MD
Aurora Diagnostics Welcomes Sophia Ma, MD, Anatomic Pathologist, to our Cascade Pathology Servicesw staff. Cascade Pathology Services is pleased to announce the addition of Sophia Ma, MD to our...
View ArticleJustin Wells, MD
Aurora Diagnostics Welcomes Justin Wells, MD, Anatomic Pathologist, to our CBM Pathology staff. CBM Pathology is pleased to announce the addition of Justin Wells, MD to our full-service Anatomic...
View ArticleSonic Healthcare USA Enhances Test Offerings with the Launch of Multiplex...
MEDIA CONTACTS: Sonic Healthcare USA Dr. Jerry Hussong, MD, MBA Chief Executive Officer jhussong@sonichealthcareusa.com 512.531.2216 Austin, TX – October 7, 2020 As flu season advances this fall in the...
View ArticleAlan Oroxom, MD
Aurora Diagnostics Welcomes Alan Oroxom, MD, Anatomic Pathologist, to our CBM Pathology staff. CBM Pathology is pleased to announce the addition of Alan Oroxom, MD to our full-service Anatomic...
View ArticleLeila Langston, MD
Aurora Diagnostics Welcomes Leila Langston, MD, Anatomic Pathologist, to our CBM Pathology staff. Arizona Dermatopathology is pleased to announce the addition of Leila Langston, MD to our full-service...
View ArticleSonic Healthcare USA is announced as a Laboratory Testing Partner for...
MEDIA CONTACTS: Sonic Healthcare USA Dr. Jerry Hussong, MD, MBA Chief Executive Officer jhussong@sonichealthcareusa.com 512.531.2216 Austin, TX – April 19, 2021 Sonic Healthcare USA (Sonic), a leading...
View ArticleSonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI...
MEDIA CONTACTS: Sonic Healthcare USA Jonathan Hughes, MD, PhD Managing Director, LMC Pathology Services communications@sonichealthcareusa.com 702.732.3441 Austin, TX – July 2, 2021 LMC Pathology...
View ArticleLMC SARS-CoV-2 Omicron Variant of Concern
On November 30, 2021, the U.S. SARS-CoV-2 Interagency Group (SIG), which includes the Centers for Disease Control and Prevention (CDC), the National Institutes of Health, the Food and Drug...
View ArticleGPA – SARS-CoV-2 Omicron Variant of Concern
On November 30, 2021, the U.S. SARS-CoV-2 Interagency Group (SIG), which includes the Centers for Disease Control and Prevention (CDC), the National Institutes of Health, the Food and Drug...
View Article
More Pages to Explore .....